Literature DB >> 20852190

Unraveling the binding mechanism of trivalent tumor necrosis factor ligands and their receptors.

Carlos R Reis1, Aart H G van Assen, Wim J Quax, Robbert H Cool.   

Abstract

Characterization of the binding of a tumor necrosis factor (TNF) ligand to its receptor(s) is pivotal to understand how these proteins initiate signal transduction pathways. Unfortunately, kinetic elucidation of these interactions is strongly hampered by the multivalent nature of the binding partners. The interaction between TNF-related apoptosis-inducing ligand and its death receptors was analyzed using in-depth applications of surface plasmon resonance technology. Variations in receptor density and sensor chip type allowed us to manipulate the stoichiometry of the formed complex, and the rate constants describing the binding of trimeric TNF-related apoptosis-inducing ligand to only one receptor molecule were determined. Remarkably, the affinity of this trimer-monomer complex is in the picomolar range, and its dissociation very slow. Further analysis showed that the second and third receptor molecules bind with lower affinity to the preformed trimer-monomer complex. This together with results obtained with receptor activator of NF-κB ligand and B cell-activating factor strongly suggests that the binding of TNF family ligands to their receptors is initiated via the formation of a trimer-monomer complex that is sufficiently stable to allow binding of two additional receptor molecules. These results suggest that avidity does not play a significant role and thus provide new insight in how TNF ligands form the biologically important complexes with their receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852190      PMCID: PMC3013454          DOI: 10.1074/mcp.M110.002808

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  23 in total

Review 1.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

2.  Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors.

Authors:  Hyun-Wook Lee; Seung-Hyun Lee; Hae-Won Lee; Yeon-Woo Ryu; Myung-Hee Kwon; Yong-Sung Kim
Journal:  Biochem Biophys Res Commun       Date:  2005-05-20       Impact factor: 3.575

3.  Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor.

Authors:  Almer M van der Sloot; Vicente Tur; Eva Szegezdi; Margaret M Mullally; Robbert H Cool; Afshin Samali; Luis Serrano; Wim J Quax
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

4.  Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

Authors:  J G Emery; P McDonnell; M B Burke; K C Deen; S Lyn; C Silverman; E Dul; E R Appelbaum; C Eichman; R DiPrinzio; R A Dodds; I E James; M Rosenberg; J C Lee; P R Young
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 5.  The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function.

Authors:  F K Chan
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

6.  Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.

Authors:  Robert F Kelley; Klara Totpal; Stephanie H Lindstrom; Mary Mathieu; Karen Billeci; Laura Deforge; Roger Pai; Sarah G Hymowitz; Avi Ashkenazi
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

7.  Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.

Authors:  Carlos R Reis; Almer M van der Sloot; Eva Szegezdi; Alessandro Natoni; Vicente Tur; Robbert H Cool; Afshin Samali; Luis Serrano; Wim J Quax
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

8.  Structure-function relationship of tumor necrosis factor (TNF) and its receptor interaction based on 3D structural analysis of a fully active TNFR1-selective TNF mutant.

Authors:  Yohei Mukai; Hiroko Shibata; Teruya Nakamura; Yasuo Yoshioka; Yasuhiro Abe; Tetsuya Nomura; Madoka Taniai; Tsunetaka Ohta; Shinji Ikemizu; Shinsaku Nakagawa; Shin-ichi Tsunoda; Haruhiko Kamada; Yuriko Yamagata; Yasuo Tsutsumi
Journal:  J Mol Biol       Date:  2008-12-06       Impact factor: 5.469

9.  Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist.

Authors:  Hiroko Shibata; Yasuo Yoshioka; Akiko Ohkawa; Kyoko Minowa; Yohei Mukai; Yasuhiro Abe; Madoka Taniai; Tetsuya Nomura; Hiroyuki Kayamuro; Hiromi Nabeshi; Toshiki Sugita; Sunao Imai; Kazuya Nagano; Tomoaki Yoshikawa; Takuya Fujita; Shinsaku Nakagawa; Akira Yamamoto; Tsunetaka Ohta; Takao Hayakawa; Tadanori Mayumi; Peter Vandenabeele; Bharat B Aggarwal; Teruya Nakamura; Yuriko Yamagata; Shin-ichi Tsunoda; Haruhiko Kamada; Yasuo Tsutsumi
Journal:  J Biol Chem       Date:  2007-11-14       Impact factor: 5.157

10.  DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design.

Authors:  Vicente Tur; Almer M van der Sloot; Carlos R Reis; Eva Szegezdi; Robbert H Cool; Afshin Samali; Luis Serrano; Wim J Quax
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

View more
  16 in total

1.  Noncompetitive inhibitors of TNFR1 probe conformational activation states.

Authors:  Chih Hung Lo; Tory M Schaaf; Benjamin D Grant; Colin Kin-Wye Lim; Prachi Bawaskar; Courtney C Aldrich; David D Thomas; Jonathan N Sachs
Journal:  Sci Signal       Date:  2019-07-30       Impact factor: 8.192

2.  Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains.

Authors:  Jinlong Jian; Shuai Zhao; Qingyun Tian; Elena Gonzalez-Gugel; Jyoti Joshi Mundra; Sardar M Z Uddin; Ben Liu; Brendon Richbourgh; Ryan Brunetti; Chuan-ju Liu
Journal:  FEBS Lett       Date:  2013-09-23       Impact factor: 4.124

3.  Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment.

Authors:  Matthieu C J Bosman; Carlos R Reis; Jan J Schuringa; Edo Vellenga; Wim J Quax
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

4.  DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.

Authors:  Rui Yu; Stella Maris Albarenque; Robbert H Cool; Wim J Quax; Andrea Mohr; Ralf M Zwacka
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

5.  Conformational states of TNFR1 as a molecular switch for receptor function.

Authors:  Chih Hung Lo; Evan C Huber; Jonathan N Sachs
Journal:  Protein Sci       Date:  2020-01-31       Impact factor: 6.725

6.  Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants.

Authors:  C R Reis; A M van der Sloot; A Natoni; E Szegezdi; R Setroikromo; M Meijer; K Sjollema; F Stricher; R H Cool; A Samali; L Serrano; W J Quax
Journal:  Cell Death Dis       Date:  2010-10-21       Impact factor: 8.469

7.  Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAIL.

Authors:  Eva Szegezdi; Almer M van der Sloot; Devalingam Mahalingam; Lynda O'Leary; Robbert H Cool; Inés G Muñoz; Guillermo Montoya; Wim J Quax; Steven de Jong; Afshin Samali; Luis Serrano
Journal:  Mol Cell Proteomics       Date:  2012-01-02       Impact factor: 5.911

8.  TRAIL-receptor preferences in pancreatic cancer cells revisited: Both TRAIL-R1 and TRAIL-R2 have a licence to kill.

Authors:  Andrea Mohr; Rui Yu; Ralf M Zwacka
Journal:  BMC Cancer       Date:  2015-07-03       Impact factor: 4.430

9.  The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity.

Authors:  Simon Neumann; Tobias Bidon; Marcus Branschädel; Anja Krippner-Heidenreich; Peter Scheurich; Malgorzata Doszczak
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

10.  Are different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?

Authors:  Nahren Manuel Mascarenhas; Johannes Kästner
Journal:  BMC Struct Biol       Date:  2012-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.